Clinical trial NCT05716204: Effects of Manual Therapy in Strenght, Pain and Functional Capacity for Sport Related Groin Pain
Official title: Effects on Pain, Strength and Functional Capacity of High Force Distraction of the Hip in Athletes With Osteitis Pubis.
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Osteitis Pubis
Athletic Pubalgia
Lead sponsor: University of Valladolid
Sponsor class: OTHER
First posted: 2023-02-08
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Athletic osteitis pubis is a pathologic entity that can cause functional impairment. Scientific evidence have noticed that athletes experiment pain and a decrease on strength. Moreover, this symptomathology can affect daily life and functionality. There is no scientific evidence about the influence of manual therapy (MT) as a single treatment to improve this condition. The investigators decided to conduct a randomized controlled trial to compare the effects of a MT technique with placebo technique.


Eligibility criteria: Inclusion Criteria:

* Athletes diagnosed with osteitis pubis stage 1 with at least 3 months of evolution.
* Internal rotation ROM limited.
* Positive provocation pain tests.

Exclusion Criteria:

* Pain due to intraarticular hip pathology.
* Hip pain due to inflamatory diseases.
* Previous surgical interventions in hip, pelvis or lumbar spine.
* MRI results or provocation pain tests inconcluyent

Primary outcomes:
measure: Strength
timeFrame: Baseline
measure: Strength
timeFrame: Through study completion, an average of two weeks
measure: Strength
timeFrame: 3 months follow-up
Secondary outcomes:
measure: Pain in sports activities
timeFrame: Baseline
measure: Pain in sports activities
timeFrame: Through study completion, an average of two weeks
measure: Pain in sports activities
timeFrame: 3 months follow-up
measure: Pain intensity during/after pain provocation tests: Single adductor, squeeze and bilateral adductor tests
timeFrame: Baseline
measure: Pain intensity after pain provocation tests: Single adductor, squeeze and bilateral adductor tests
timeFrame: Through study completion, an average of two weeks
measure: Pain intensity after pain provocation tests: Single adductor, squeeze and bilateral adductor tests
timeFrame: 3 months follow-up
measure: Functional capacity
timeFrame: Baseline
measure: Functional capacity
timeFrame: Through study completion, an average of two weeks
measure: Functional capacity
timeFrame: 3 months follow-up
Other outcomes:
measure: Treatment expectancy and credibility
timeFrame: Through study completion, an average of two weeks
measure: Treatment expectancy and credibility
timeFrame: 3 months follow-up
Locations:
city: Soria
country: Spain
facility: Silvia Lahuerta Martín
Study officials:
affiliation: University of Valladolid
name: Silvia Lahuerta Martín
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Valladolid
name: Luis Ceballos Laita
role: STUDY_DIRECTOR
affiliation: University of Valladolid
name: Sandra Jiménez del Barrio
role: STUDY_DIRECTOR
affiliation: University of Valladolid
name: Maria Teresa Mingo Gómez
role: STUDY_DIRECTOR
References:
citation: Verrall GM, Slavotinek JP, Barnes PG, Fon GT. Description of pain provocation tests used for the diagnosis of sports-related chronic groin pain: relationship of tests to defined clinical (pain and tenderness) and MRI (pubic bone marrow oedema) criteria. Scand J Med Sci Sports. 2005 Feb;15(1):36-42. doi: 10.1111/j.1600-0838.2004.00380.x.
citation: Thorborg K, Holmich P, Christensen R, Petersen J, Roos EM. The Copenhagen Hip and Groin Outcome Score (HAGOS): development and validation according to the COSMIN checklist. Br J Sports Med. 2011 May;45(6):478-91. doi: 10.1136/bjsm.2010.080937.
citation: Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86. doi: 10.1016/s0005-7916(00)00012-4.